

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of erythrocyte differentiation (GO:0045647) | 5.74839077 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.24471699 |
| 3 | negative regulation of cell killing (GO:0031342) | 5.01618205 |
| 4 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.01618205 |
| 5 | mannose metabolic process (GO:0006013) | 4.68765945 |
| 6 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.62759599 |
| 7 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.46382502 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.44496757 |
| 9 | * Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.41174081 |
| 10 | response to muramyl dipeptide (GO:0032495) | 4.26925390 |
| 11 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.25179058 |
| 12 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.24262109 |
| 13 | positive thymic T cell selection (GO:0045059) | 4.19365497 |
| 14 | detection of bacterium (GO:0016045) | 3.96248090 |
| 15 | regulation of gamma-delta T cell activation (GO:0046643) | 3.93018361 |
| 16 | thymic T cell selection (GO:0045061) | 3.91528592 |
| 17 | response to peptidoglycan (GO:0032494) | 3.80072959 |
| 18 | detection of other organism (GO:0098543) | 3.73560667 |
| 19 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.65743825 |
| 20 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.60985911 |
| 21 | positive regulation by symbiont of host defense response (GO:0052509) | 3.59501887 |
| 22 | modulation by symbiont of host defense response (GO:0052031) | 3.59501887 |
| 23 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.59501887 |
| 24 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.59501887 |
| 25 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.59501887 |
| 26 | modulation by symbiont of host immune response (GO:0052553) | 3.59501887 |
| 27 | NIK/NF-kappaB signaling (GO:0038061) | 3.51782429 |
| 28 | neutrophil activation involved in immune response (GO:0002283) | 3.50733914 |
| 29 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.50667192 |
| 30 | positive regulation of B cell differentiation (GO:0045579) | 3.50463104 |
| 31 | negative thymic T cell selection (GO:0045060) | 3.47706225 |
| 32 | * actin nucleation (GO:0045010) | 3.43143476 |
| 33 | B cell receptor signaling pathway (GO:0050853) | 3.42618774 |
| 34 | T cell selection (GO:0045058) | 3.37396306 |
| 35 | regulation of ARF GTPase activity (GO:0032312) | 3.36162875 |
| 36 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.27951126 |
| 37 | negative T cell selection (GO:0043383) | 3.26889289 |
| 38 | macrophage activation involved in immune response (GO:0002281) | 3.25284779 |
| 39 | leukocyte aggregation (GO:0070486) | 3.15810271 |
| 40 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.15408910 |
| 41 | germinal center formation (GO:0002467) | 3.13266736 |
| 42 | positive T cell selection (GO:0043368) | 3.12937474 |
| 43 | negative regulation of granulocyte differentiation (GO:0030853) | 3.12601584 |
| 44 | modulation by virus of host process (GO:0019054) | 3.11310191 |
| 45 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.11229904 |
| 46 | regulation of mast cell degranulation (GO:0043304) | 3.10770439 |
| 47 | negative regulation of innate immune response (GO:0045824) | 3.09639377 |
| 48 | negative regulation of interleukin-12 production (GO:0032695) | 3.08180799 |
| 49 | immunoglobulin mediated immune response (GO:0016064) | 3.03895881 |
| 50 | negative regulation of T cell mediated immunity (GO:0002710) | 2.96603347 |
| 51 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.94867103 |
| 52 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.93452038 |
| 53 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.92159841 |
| 54 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.91993300 |
| 55 | positive regulation of protein kinase C signaling (GO:0090037) | 2.91890553 |
| 56 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.90024544 |
| 57 | detection of external biotic stimulus (GO:0098581) | 2.83770068 |
| 58 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 2.83060609 |
| 59 | regulation of B cell differentiation (GO:0045577) | 2.82569708 |
| 60 | regulation of leukocyte degranulation (GO:0043300) | 2.81945773 |
| 61 | response to protozoan (GO:0001562) | 2.81315587 |
| 62 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.81187208 |
| 63 | Peyers patch development (GO:0048541) | 2.81187208 |
| 64 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.80726448 |
| 65 | response to interleukin-15 (GO:0070672) | 2.80591550 |
| 66 | defense response to protozoan (GO:0042832) | 2.75963495 |
| 67 | response to type I interferon (GO:0034340) | 2.75016628 |
| 68 | adenosine receptor signaling pathway (GO:0001973) | 2.74819997 |
| 69 | modulation by symbiont of host cellular process (GO:0044068) | 2.71487287 |
| 70 | regulation of granulocyte differentiation (GO:0030852) | 2.71283790 |
| 71 | positive regulation of antigen processing and presentation (GO:0002579) | 2.71012142 |
| 72 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.68426424 |
| 73 | cellular response to virus (GO:0098586) | 2.67815816 |
| 74 | regulation of antigen processing and presentation (GO:0002577) | 2.66762283 |
| 75 | cellular response to type I interferon (GO:0071357) | 2.66197074 |
| 76 | type I interferon signaling pathway (GO:0060337) | 2.66197074 |
| 77 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.65874079 |
| 78 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.65874079 |
| 79 | tolerance induction (GO:0002507) | 2.62953456 |
| 80 | histone H4 deacetylation (GO:0070933) | 2.62691296 |
| 81 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.62599229 |
| 82 | myeloid cell activation involved in immune response (GO:0002275) | 2.61484940 |
| 83 | respiratory burst (GO:0045730) | 2.61321042 |
| 84 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.61187230 |
| 85 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.60595609 |
| 86 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.60232660 |
| 87 | positive regulation of histone deacetylation (GO:0031065) | 2.60019050 |
| 88 | neutrophil activation (GO:0042119) | 2.59704425 |
| 89 | granulocyte activation (GO:0036230) | 2.58920454 |
| 90 | T cell migration (GO:0072678) | 2.58742046 |
| 91 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.58401338 |
| 92 | detection of biotic stimulus (GO:0009595) | 2.57932586 |
| 93 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 2.57443221 |
| 94 | regulation of monocyte differentiation (GO:0045655) | 2.55662663 |
| 95 | regulation of tumor necrosis factor superfamily cytokine production (GO:1903555) | 2.54188739 |
| 96 | activated T cell proliferation (GO:0050798) | 2.51800987 |
| 97 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.51747667 |
| 98 | GDP-mannose metabolic process (GO:0019673) | 2.49223045 |
| 99 | negative regulation of interleukin-6 production (GO:0032715) | 2.48280508 |
| 100 | regulation of tumor necrosis factor production (GO:0032680) | 2.47853555 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.92598455 |
| 2 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.99572064 |
| 3 | MYC_22102868_ChIP-Seq_BL_Human | 2.93127650 |
| 4 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.69051161 |
| 5 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.63569207 |
| 6 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.59794730 |
| 7 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.49259732 |
| 8 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.42688849 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.42584958 |
| 10 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.36608791 |
| 11 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.36252160 |
| 12 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.30002963 |
| 13 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.26404160 |
| 14 | MAF_26560356_Chip-Seq_TH1_Human | 2.20884598 |
| 15 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.19817984 |
| 16 | MAF_26560356_Chip-Seq_TH2_Human | 2.17598114 |
| 17 | * CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.17323903 |
| 18 | P68_20966046_ChIP-Seq_HELA_Human | 2.17019553 |
| 19 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.09378019 |
| 20 | UTX_26944678_Chip-Seq_JUKART_Human | 2.07847923 |
| 21 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.04560230 |
| 22 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.01911977 |
| 23 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.95568870 |
| 24 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.95560062 |
| 25 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.89817833 |
| 26 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.82702531 |
| 27 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.81406606 |
| 28 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.80550056 |
| 29 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.79959807 |
| 30 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.78946318 |
| 31 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.76534642 |
| 32 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.76328652 |
| 33 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.76191963 |
| 34 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.72386738 |
| 35 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.69442976 |
| 36 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.66603015 |
| 37 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.65345942 |
| 38 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.65064049 |
| 39 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62767141 |
| 40 | KDM2B_26808549_Chip-Seq_K562_Human | 1.61987394 |
| 41 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.59511575 |
| 42 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.56046207 |
| 43 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.55609195 |
| 44 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.53233384 |
| 45 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.49529997 |
| 46 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.48917003 |
| 47 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.46350812 |
| 48 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.45176476 |
| 49 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.44700848 |
| 50 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.44536151 |
| 51 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.43802707 |
| 52 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.43512625 |
| 53 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.43429802 |
| 54 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.43205556 |
| 55 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.42066792 |
| 56 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.38733378 |
| 57 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.38646212 |
| 58 | SPI1_23127762_ChIP-Seq_K562_Human | 1.38632742 |
| 59 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.36058169 |
| 60 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.35585088 |
| 61 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.35403410 |
| 62 | SA1_27219007_Chip-Seq_Bcells_Human | 1.33983649 |
| 63 | GATA1_19941826_ChIP-Seq_K562_Human | 1.33845008 |
| 64 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.33697121 |
| 65 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32158184 |
| 66 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.32029651 |
| 67 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.31315694 |
| 68 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.30984922 |
| 69 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.28047750 |
| 70 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.27989888 |
| 71 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.26995290 |
| 72 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.26560983 |
| 73 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.26167352 |
| 74 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.25086937 |
| 75 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.24603030 |
| 76 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.22629664 |
| 77 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.19051751 |
| 78 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.16452232 |
| 79 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.15039232 |
| 80 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.14980790 |
| 81 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14590765 |
| 82 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.14053498 |
| 83 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.13985419 |
| 84 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.13167538 |
| 85 | MYB_26560356_Chip-Seq_TH1_Human | 1.12557963 |
| 86 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.12470503 |
| 87 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.12124486 |
| 88 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11832765 |
| 89 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10002545 |
| 90 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.09781554 |
| 91 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.09628429 |
| 92 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09145325 |
| 93 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.08864282 |
| 94 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.08195337 |
| 95 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.08145832 |
| 96 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.07863181 |
| 97 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.06861541 |
| 98 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.05429924 |
| 99 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05156849 |
| 100 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.05107768 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003436_decreased_susceptibility_to | 4.08108572 |
| 2 | MP0003303_peritoneal_inflammation | 3.35887636 |
| 3 | MP0005058_abnormal_lysosome_morphology | 2.76290920 |
| 4 | MP0003172_abnormal_lysosome_physiology | 2.67870085 |
| 5 | MP0009278_abnormal_bone_marrow | 2.61357169 |
| 6 | MP0001800_abnormal_humoral_immune | 2.59916926 |
| 7 | MP0005025_abnormal_response_to | 2.59376532 |
| 8 | MP0003724_increased_susceptibility_to | 2.58302464 |
| 9 | MP0001790_abnormal_immune_system | 2.57926971 |
| 10 | MP0005387_immune_system_phenotype | 2.57926971 |
| 11 | MP0005671_abnormal_response_to | 2.56940073 |
| 12 | MP0001835_abnormal_antigen_presentation | 2.55847408 |
| 13 | MP0000685_abnormal_immune_system | 2.47133879 |
| 14 | MP0002419_abnormal_innate_immunity | 2.41070458 |
| 15 | MP0005000_abnormal_immune_tolerance | 2.38469370 |
| 16 | MP0002723_abnormal_immune_serum | 2.31700491 |
| 17 | MP0003763_abnormal_thymus_physiology | 2.31526738 |
| 18 | MP0001986_abnormal_taste_sensitivity | 2.23593538 |
| 19 | MP0002420_abnormal_adaptive_immunity | 2.22759077 |
| 20 | MP0001819_abnormal_immune_cell | 2.21092524 |
| 21 | MP0002452_abnormal_antigen_presenting | 2.14493699 |
| 22 | MP0009333_abnormal_splenocyte_physiolog | 2.09179716 |
| 23 | MP0010155_abnormal_intestine_physiology | 2.04520500 |
| 24 | MP0009379_abnormal_foot_pigmentation | 2.01802204 |
| 25 | MP0001873_stomach_inflammation | 2.01749343 |
| 26 | MP0009785_altered_susceptibility_to | 1.95870353 |
| 27 | MP0005464_abnormal_platelet_physiology | 1.91967467 |
| 28 | MP0004947_skin_inflammation | 1.89683784 |
| 29 | MP0002148_abnormal_hypersensitivity_rea | 1.88377335 |
| 30 | MP0004381_abnormal_hair_follicle | 1.86943060 |
| 31 | MP0002398_abnormal_bone_marrow | 1.86629798 |
| 32 | MP0000716_abnormal_immune_system | 1.78511944 |
| 33 | MP0002405_respiratory_system_inflammati | 1.77117017 |
| 34 | MP0002933_joint_inflammation | 1.64285230 |
| 35 | MP0001533_abnormal_skeleton_physiology | 1.60480002 |
| 36 | MP0008260_abnormal_autophagy | 1.60094803 |
| 37 | MP0003866_abnormal_defecation | 1.58771717 |
| 38 | MP0001545_abnormal_hematopoietic_system | 1.58181797 |
| 39 | MP0005397_hematopoietic_system_phenotyp | 1.58181797 |
| 40 | MP0003183_abnormal_peptide_metabolism | 1.52150638 |
| 41 | MP0002429_abnormal_blood_cell | 1.50517340 |
| 42 | MP0002722_abnormal_immune_system | 1.49329379 |
| 43 | MP0000689_abnormal_spleen_morphology | 1.48684227 |
| 44 | MP0006082_CNS_inflammation | 1.46091854 |
| 45 | MP0005083_abnormal_biliary_tract | 1.45068767 |
| 46 | MP0001845_abnormal_inflammatory_respons | 1.44701748 |
| 47 | MP0003300_gastrointestinal_ulcer | 1.44366800 |
| 48 | MP0000703_abnormal_thymus_morphology | 1.42601324 |
| 49 | MP0001663_abnormal_digestive_system | 1.31678556 |
| 50 | MP0002138_abnormal_hepatobiliary_system | 1.30104125 |
| 51 | MP0009840_abnormal_foam_cell | 1.29926662 |
| 52 | MP0005409_darkened_coat_color | 1.27719384 |
| 53 | MP0005174_abnormal_tail_pigmentation | 1.22575836 |
| 54 | MP0000465_gastrointestinal_hemorrhage | 1.21753706 |
| 55 | MP0004510_myositis | 1.20688877 |
| 56 | MP0004130_abnormal_muscle_cell | 1.19336762 |
| 57 | MP0005076_abnormal_cell_differentiation | 1.16610244 |
| 58 | MP0008469_abnormal_protein_level | 1.16520031 |
| 59 | MP0003879_abnormal_hair_cell | 1.14526721 |
| 60 | MP0002249_abnormal_larynx_morphology | 1.09260154 |
| 61 | MP0009764_decreased_sensitivity_to | 1.09084747 |
| 62 | MP0004858_abnormal_nervous_system | 1.08760280 |
| 63 | MP0002396_abnormal_hematopoietic_system | 1.08415544 |
| 64 | MP0005451_abnormal_body_composition | 1.08180975 |
| 65 | MP0002998_abnormal_bone_remodeling | 1.08174058 |
| 66 | MP0001849_ear_inflammation | 1.08152849 |
| 67 | MP0000015_abnormal_ear_pigmentation | 1.07967218 |
| 68 | MP0005423_abnormal_somatic_nervous | 1.03181498 |
| 69 | MP0003191_abnormal_cellular_cholesterol | 1.02649998 |
| 70 | MP0000858_altered_metastatic_potential | 1.02510143 |
| 71 | MP0004185_abnormal_adipocyte_glucose | 0.98841225 |
| 72 | MP0003453_abnormal_keratinocyte_physiol | 0.97894151 |
| 73 | MP0003705_abnormal_hypodermis_morpholog | 0.97101830 |
| 74 | MP0000678_abnormal_parathyroid_gland | 0.94687612 |
| 75 | MP0005377_hearing/vestibular/ear_phenot | 0.92803158 |
| 76 | MP0003878_abnormal_ear_physiology | 0.92803158 |
| 77 | MP0002132_abnormal_respiratory_system | 0.92418948 |
| 78 | MP0003828_pulmonary_edema | 0.86211158 |
| 79 | MP0000604_amyloidosis | 0.85867077 |
| 80 | MP0005381_digestive/alimentary_phenotyp | 0.85751746 |
| 81 | MP0005666_abnormal_adipose_tissue | 0.85642944 |
| 82 | MP0000490_abnormal_crypts_of | 0.85577779 |
| 83 | MP0003329_amyloid_beta_deposits | 0.82844653 |
| 84 | MP0003136_yellow_coat_color | 0.80966637 |
| 85 | MP0001765_abnormal_ion_homeostasis | 0.79484210 |
| 86 | MP0005535_abnormal_body_temperature | 0.78437206 |
| 87 | MP0008874_decreased_physiological_sensi | 0.73708030 |
| 88 | MP0001502_abnormal_circadian_rhythm | 0.72382909 |
| 89 | MP0005390_skeleton_phenotype | 0.71988604 |
| 90 | MP0005310_abnormal_salivary_gland | 0.71768254 |
| 91 | MP0001188_hyperpigmentation | 0.71289807 |
| 92 | MP0005375_adipose_tissue_phenotype | 0.70464964 |
| 93 | MP0002822_catalepsy | 0.68744097 |
| 94 | MP0003656_abnormal_erythrocyte_physiolo | 0.66473947 |
| 95 | MP0001348_abnormal_lacrimal_gland | 0.66392952 |
| 96 | MP0002653_abnormal_ependyma_morphology | 0.66050256 |
| 97 | MP0004808_abnormal_hematopoietic_stem | 0.64722272 |
| 98 | MP0009931_abnormal_skin_appearance | 0.64663583 |
| 99 | MP0002136_abnormal_kidney_physiology | 0.59436510 |
| 100 | MP0002019_abnormal_tumor_incidence | 0.55565515 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.79136089 |
| 2 | Chronic obstructive pulmonary disease (HP:0006510) | 3.63438656 |
| 3 | Obstructive lung disease (HP:0006536) | 3.63438656 |
| 4 | Recurrent abscess formation (HP:0002722) | 3.62418338 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 3.62398266 |
| 6 | Thin bony cortex (HP:0002753) | 3.56520601 |
| 7 | Abnormality of macrophages (HP:0004311) | 3.52361648 |
| 8 | Myositis (HP:0100614) | 3.52092851 |
| 9 | Colitis (HP:0002583) | 3.44595289 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.36724206 |
| 11 | Mediastinal lymphadenopathy (HP:0100721) | 3.34040362 |
| 12 | Prolonged bleeding time (HP:0003010) | 3.30986842 |
| 13 | Recurrent fungal infections (HP:0002841) | 3.24117702 |
| 14 | Gastrointestinal infarctions (HP:0005244) | 3.19592050 |
| 15 | Meningitis (HP:0001287) | 3.17127500 |
| 16 | Increased IgE level (HP:0003212) | 3.11508726 |
| 17 | Panhypogammaglobulinemia (HP:0003139) | 3.08131211 |
| 18 | Pustule (HP:0200039) | 3.06925788 |
| 19 | Gastrointestinal inflammation (HP:0004386) | 3.05558060 |
| 20 | Annular pancreas (HP:0001734) | 2.98215428 |
| 21 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.89657260 |
| 22 | Orchitis (HP:0100796) | 2.87912596 |
| 23 | Inflammation of the large intestine (HP:0002037) | 2.87671340 |
| 24 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.87627337 |
| 25 | Recurrent cutaneous fungal infections (HP:0011370) | 2.87627337 |
| 26 | Dysostosis multiplex (HP:0000943) | 2.83171399 |
| 27 | Cellulitis (HP:0100658) | 2.79273576 |
| 28 | Purpura (HP:0000979) | 2.76528902 |
| 29 | Obstructive sleep apnea (HP:0002870) | 2.70522682 |
| 30 | Encephalitis (HP:0002383) | 2.67541063 |
| 31 | Hemorrhage of the eye (HP:0011885) | 2.65047140 |
| 32 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.64628401 |
| 33 | Increased cerebral lipofuscin (HP:0011813) | 2.61855029 |
| 34 | Abnormality of the fingertips (HP:0001211) | 2.60433808 |
| 35 | Malnutrition (HP:0004395) | 2.58209612 |
| 36 | Recurrent skin infections (HP:0001581) | 2.57621834 |
| 37 | Petechiae (HP:0000967) | 2.57223452 |
| 38 | Increased serum ferritin (HP:0003281) | 2.54613986 |
| 39 | Gingivitis (HP:0000230) | 2.54199298 |
| 40 | Agammaglobulinemia (HP:0004432) | 2.52990645 |
| 41 | Hypochromic anemia (HP:0001931) | 2.52244757 |
| 42 | Retrobulbar optic neuritis (HP:0100654) | 2.51466465 |
| 43 | Optic neuritis (HP:0100653) | 2.51466465 |
| 44 | Hypertensive crisis (HP:0100735) | 2.48668766 |
| 45 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.48617412 |
| 46 | Epistaxis (HP:0000421) | 2.48047278 |
| 47 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.46777437 |
| 48 | Recurrent viral infections (HP:0004429) | 2.44948755 |
| 49 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.40370497 |
| 50 | Vasculitis (HP:0002633) | 2.38762849 |
| 51 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.35142973 |
| 52 | Stomatitis (HP:0010280) | 2.33304310 |
| 53 | Joint stiffness (HP:0001387) | 2.33133293 |
| 54 | Spontaneous hematomas (HP:0007420) | 2.32886496 |
| 55 | Chest pain (HP:0100749) | 2.31788297 |
| 56 | Emphysema (HP:0002097) | 2.31357187 |
| 57 | Abnormal number of erythroid precursors (HP:0012131) | 2.27136061 |
| 58 | Thoracic kyphosis (HP:0002942) | 2.24914943 |
| 59 | Hemoptysis (HP:0002105) | 2.24862331 |
| 60 | Myopathic facies (HP:0002058) | 2.23988962 |
| 61 | Easy fatigability (HP:0003388) | 2.20660625 |
| 62 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.17206192 |
| 63 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.17206192 |
| 64 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.17206192 |
| 65 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.15593079 |
| 66 | Seborrheic dermatitis (HP:0001051) | 2.11591920 |
| 67 | Mucopolysacchariduria (HP:0008155) | 2.10244713 |
| 68 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.10244713 |
| 69 | Metaphyseal cupping (HP:0003021) | 2.09772655 |
| 70 | J-shaped sella turcica (HP:0002680) | 2.05183231 |
| 71 | Abnormality of iron homeostasis (HP:0011031) | 2.04822221 |
| 72 | Gastrointestinal stroma tumor (HP:0100723) | 2.04730030 |
| 73 | Systemic lupus erythematosus (HP:0002725) | 2.03338590 |
| 74 | Granulocytopenia (HP:0001913) | 2.02225248 |
| 75 | Thrombocytosis (HP:0001894) | 2.01404759 |
| 76 | Abnormality of the thoracic spine (HP:0100711) | 2.01386650 |
| 77 | Broad face (HP:0000283) | 1.98891295 |
| 78 | Pulmonary infiltrates (HP:0002113) | 1.97026750 |
| 79 | Impaired platelet aggregation (HP:0003540) | 1.94493112 |
| 80 | Abnormal platelet function (HP:0011869) | 1.94493112 |
| 81 | Nasal polyposis (HP:0100582) | 1.92831501 |
| 82 | Increased IgM level (HP:0003496) | 1.91948300 |
| 83 | Abnormality of the nasal mucosa (HP:0000433) | 1.90758790 |
| 84 | Rib fusion (HP:0000902) | 1.90604995 |
| 85 | Reticulocytosis (HP:0001923) | 1.88959860 |
| 86 | Abnormality of glycolipid metabolism (HP:0010969) | 1.86619312 |
| 87 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.86619312 |
| 88 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.86619312 |
| 89 | Hypertriglyceridemia (HP:0002155) | 1.86602253 |
| 90 | Pallor (HP:0000980) | 1.86552265 |
| 91 | Restrictive lung disease (HP:0002091) | 1.80996903 |
| 92 | Hypophosphatemia (HP:0002148) | 1.79738767 |
| 93 | Spinal canal stenosis (HP:0003416) | 1.79524942 |
| 94 | Acne (HP:0001061) | 1.77229691 |
| 95 | Urticaria (HP:0001025) | 1.76991493 |
| 96 | Truncus arteriosus (HP:0001660) | 1.73736168 |
| 97 | Keratoconjunctivitis sicca (HP:0001097) | 1.73078078 |
| 98 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.72352081 |
| 99 | Lymphopenia (HP:0001888) | 1.71971459 |
| 100 | Hyperthyroidism (HP:0000836) | 1.71462453 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.36756219 |
| 2 | TRIB3 | 3.30296362 |
| 3 | RIPK4 | 3.05033762 |
| 4 | ERN1 | 3.00705794 |
| 5 | SIK1 | 2.51561347 |
| 6 | SIK2 | 2.37650719 |
| 7 | BLK | 2.25175400 |
| 8 | MAP2K3 | 2.22541370 |
| 9 | PRPF4B | 2.16298529 |
| 10 | TNK2 | 2.03475074 |
| 11 | GRK6 | 1.95180845 |
| 12 | MAP3K11 | 1.93153435 |
| 13 | BTK | 1.80336560 |
| 14 | MARK2 | 1.73848171 |
| 15 | FES | 1.72379961 |
| 16 | ZAP70 | 1.67085841 |
| 17 | TYK2 | 1.66157223 |
| 18 | TBK1 | 1.60928296 |
| 19 | MAPK15 | 1.58794371 |
| 20 | IRAK4 | 1.52237616 |
| 21 | CSK | 1.45323921 |
| 22 | MAP3K13 | 1.44925750 |
| 23 | PRKD2 | 1.38633122 |
| 24 | TESK2 | 1.35279456 |
| 25 | SYK | 1.31082556 |
| 26 | MAP3K7 | 1.29743105 |
| 27 | SMG1 | 1.29609283 |
| 28 | ICK | 1.26438819 |
| 29 | TXK | 1.25579020 |
| 30 | MAP2K6 | 1.25477259 |
| 31 | MAP3K14 | 1.23974935 |
| 32 | MAP3K10 | 1.23933985 |
| 33 | CDC42BPA | 1.20297579 |
| 34 | IKBKE | 1.17068658 |
| 35 | RPS6KL1 | 1.16241074 |
| 36 | RPS6KC1 | 1.16241074 |
| 37 | JAK3 | 1.13742266 |
| 38 | IKBKB | 1.12981497 |
| 39 | MATK | 1.09946393 |
| 40 | EEF2K | 1.09510690 |
| 41 | PTK6 | 1.09078617 |
| 42 | EPHB1 | 1.08756807 |
| 43 | TAOK1 | 1.05798346 |
| 44 | RPS6KA6 | 1.05105092 |
| 45 | SIK3 | 1.03180132 |
| 46 | MAP2K2 | 1.02975038 |
| 47 | RPS6KA2 | 1.01758029 |
| 48 | DYRK1B | 1.01195536 |
| 49 | HCK | 1.00906693 |
| 50 | RIPK1 | 1.00083565 |
| 51 | TLK1 | 0.98969499 |
| 52 | MAP3K1 | 0.98359032 |
| 53 | FGFR4 | 0.97212336 |
| 54 | MAPK12 | 0.96863807 |
| 55 | LYN | 0.95765321 |
| 56 | BMX | 0.95353735 |
| 57 | ITK | 0.94772974 |
| 58 | MAP3K6 | 0.93297614 |
| 59 | NME2 | 0.91348369 |
| 60 | TYRO3 | 0.91346474 |
| 61 | LCK | 0.90195174 |
| 62 | PKN2 | 0.89117609 |
| 63 | TAOK3 | 0.88719560 |
| 64 | KIT | 0.86746525 |
| 65 | TAOK2 | 0.85124841 |
| 66 | HIPK2 | 0.81653592 |
| 67 | CSF1R | 0.77345452 |
| 68 | MARK3 | 0.75012888 |
| 69 | PDPK1 | 0.74850803 |
| 70 | IRAK3 | 0.73096236 |
| 71 | CAMKK1 | 0.71003477 |
| 72 | WNK4 | 0.70673482 |
| 73 | CDK4 | 0.68559184 |
| 74 | JAK2 | 0.67484501 |
| 75 | CDK12 | 0.67287586 |
| 76 | MAPK7 | 0.65520963 |
| 77 | MAP3K3 | 0.65438969 |
| 78 | JAK1 | 0.62871278 |
| 79 | KDR | 0.61599112 |
| 80 | FGR | 0.60534262 |
| 81 | MAPK11 | 0.58464907 |
| 82 | PDK1 | 0.56792092 |
| 83 | PRKCQ | 0.55986683 |
| 84 | PRKCH | 0.55550563 |
| 85 | MST1R | 0.55029217 |
| 86 | MAP2K4 | 0.52070950 |
| 87 | MTOR | 0.51306735 |
| 88 | LRRK2 | 0.49726074 |
| 89 | TEC | 0.49395149 |
| 90 | PIM2 | 0.48817348 |
| 91 | FYN | 0.47937792 |
| 92 | PIM1 | 0.46656027 |
| 93 | IRAK2 | 0.46591998 |
| 94 | RET | 0.46387829 |
| 95 | CHUK | 0.46235265 |
| 96 | MAPK4 | 0.44488727 |
| 97 | RPS6KA1 | 0.44148838 |
| 98 | STK11 | 0.42592189 |
| 99 | MAPK3 | 0.42178587 |
| 100 | DDR2 | 0.41501548 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 3.26361365 |
| 2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.23497400 |
| 3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.20611078 |
| 4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.20386205 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.10873773 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.02938755 |
| 7 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.95622541 |
| 8 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.93915162 |
| 9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.91379299 |
| 10 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.87959079 |
| 11 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.86135147 |
| 12 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.79243322 |
| 13 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.72903137 |
| 14 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.71016957 |
| 15 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.69149287 |
| 16 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.67544563 |
| 17 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.61220526 |
| 18 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.54620205 |
| 19 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.53305952 |
| 20 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.48309006 |
| 21 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.48282312 |
| 22 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.46017817 |
| 23 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.45489559 |
| 24 | Tuberculosis_Homo sapiens_hsa05152 | 1.44470870 |
| 25 | Asthma_Homo sapiens_hsa05310 | 1.44454343 |
| 26 | Sulfur relay system_Homo sapiens_hsa04122 | 1.41673569 |
| 27 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.34727353 |
| 28 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.31981629 |
| 29 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.29596333 |
| 30 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.24017633 |
| 31 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.22792521 |
| 32 | Influenza A_Homo sapiens_hsa05164 | 1.21908068 |
| 33 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.21399764 |
| 34 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.19751990 |
| 35 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.15686405 |
| 36 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.13417218 |
| 37 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.12489876 |
| 38 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.11732165 |
| 39 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.10941946 |
| 40 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.10620704 |
| 41 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.08848477 |
| 42 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.08050490 |
| 43 | Viral myocarditis_Homo sapiens_hsa05416 | 1.04712623 |
| 44 | Lysosome_Homo sapiens_hsa04142 | 1.03726529 |
| 45 | Malaria_Homo sapiens_hsa05144 | 1.01176674 |
| 46 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.01137236 |
| 47 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.00883665 |
| 48 | Measles_Homo sapiens_hsa05162 | 0.98449107 |
| 49 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.97214793 |
| 50 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.96765903 |
| 51 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.96698173 |
| 52 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.96427233 |
| 53 | Platelet activation_Homo sapiens_hsa04611 | 0.96248934 |
| 54 | Hepatitis C_Homo sapiens_hsa05160 | 0.95800624 |
| 55 | Hepatitis B_Homo sapiens_hsa05161 | 0.92930477 |
| 56 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.91735091 |
| 57 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.83457609 |
| 58 | Endocytosis_Homo sapiens_hsa04144 | 0.82880259 |
| 59 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.82312121 |
| 60 | Apoptosis_Homo sapiens_hsa04210 | 0.81084308 |
| 61 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.80437189 |
| 62 | Pertussis_Homo sapiens_hsa05133 | 0.80300811 |
| 63 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.78288674 |
| 64 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.78283068 |
| 65 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.76706676 |
| 66 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.75564887 |
| 67 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.75490587 |
| 68 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.75145734 |
| 69 | Bladder cancer_Homo sapiens_hsa05219 | 0.73521598 |
| 70 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.73222043 |
| 71 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.73045636 |
| 72 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.72523685 |
| 73 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.71146346 |
| 74 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.69977156 |
| 75 | Salmonella infection_Homo sapiens_hsa05132 | 0.69508536 |
| 76 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.67061082 |
| 77 | HTLV-I infection_Homo sapiens_hsa05166 | 0.66785075 |
| 78 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.66292093 |
| 79 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.64307174 |
| 80 | Phagosome_Homo sapiens_hsa04145 | 0.64181016 |
| 81 | Insulin resistance_Homo sapiens_hsa04931 | 0.63029785 |
| 82 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.61912389 |
| 83 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.59180428 |
| 84 | Shigellosis_Homo sapiens_hsa05131 | 0.57350780 |
| 85 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.55480924 |
| 86 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.55242020 |
| 87 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.53457827 |
| 88 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.53345348 |
| 89 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.47648485 |
| 90 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.46380496 |
| 91 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.45399533 |
| 92 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.43120363 |
| 93 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.42422621 |
| 94 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.42273087 |
| 95 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.40311895 |
| 96 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.40157316 |
| 97 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.39966255 |
| 98 | ABC transporters_Homo sapiens_hsa02010 | 0.39435164 |
| 99 | Ribosome_Homo sapiens_hsa03010 | 0.39240645 |
| 100 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.37951159 |

